We are live on ! Find out more
LIXTW

Lixte Biotechnology Warrants
LIXTW

Delisted

LIXTW was delisted on the 26th of November, 2025.

Back to rankings

3 hedge funds and large institutions have $1.65K invested in Lixte Biotechnology Warrants in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

14% more capital invested

Capital invested by funds: $1.44K → $1.65K (+$205)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.05% less ownership

Funds ownership: 2.22% → 2.17% (-0.05%)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$3
2
CS
Clear Street
New York
+$3

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$44
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$880 -$44 -1,300 -5%
CS
2
Clear Street
New York
$766 +$3 +100 +0.4%
Bank of America
3
Bank of America
North Carolina
$2 +$3 +100 New

LIXTW Hedge Fund Activity: Q1 2025 in Review

3 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Lixte Biotechnology Warrants (LIXTW) for Q1 2025, worth a combined $1.65K — up 14% from $1.44K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new LIXTW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $3. The largest seller was Citadel Advisors, cutting an estimated $44.

  • 3 institutional investors held Lixte Biotechnology Warrants (LIXTW) as of Q1 2025, up from 2 in Q4 2024.
  • Funds reported $1.65K of Lixte Biotechnology Warrants stock for Q1 2025, up 14% quarter-over-quarter.
  • 1 fund opened new Lixte Biotechnology Warrants positions in Q1 2025 and 0 closed out, a net change of +1 holder.
  • The largest Lixte Biotechnology Warrants buyer in Q1 2025 was Bank of America, an estimated $3 added.
  • The largest Lixte Biotechnology Warrants seller in Q1 2025 was Citadel Advisors, an estimated $44 sold.

Based on aggregated 13F filings for Q1 2025.